These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 20637768)

  • 21. Cytokine mRNA expression profiles in peripheral blood mononuclear cells from piglets experimentally co-infected with porcine reproductive and respiratory syndrome virus and porcine circovirus type 2.
    Shi KC; Guo X; Ge XN; Liu Q; Yang HC
    Vet Microbiol; 2010 Jan; 140(1-2):155-60. PubMed ID: 19854008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs.
    Fenaux M; Opriessnig T; Halbur PG; Elvinger F; Meng XJ
    J Virol; 2004 Jun; 78(12):6297-303. PubMed ID: 15163723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of efficacy of commercial one dose and two dose PCV2 vaccines using a mixed PRRSV-PCV2-SIV clinical infection model 2-3-months post vaccination.
    Opriessnig T; Patterson AR; Madson DM; Pal N; Halbur PG
    Vaccine; 2009 Feb; 27(7):1002-7. PubMed ID: 19100807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.
    Martelli P; Gozio S; Ferrari L; Rosina S; De Angelis E; Quintavalla C; Bottarelli E; Borghetti P
    Vaccine; 2009 Jun; 27(28):3788-99. PubMed ID: 19442420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the effectiveness of passive (dam) versus active (piglet) immunization against porcine circovirus type 2 (PCV2) and impact of passively derived PCV2 vaccine-induced immunity on vaccination.
    Opriessnig T; Patterson AR; Madson DM; Pal N; Ramamoorthy S; Meng XJ; Halbur PG
    Vet Microbiol; 2010 May; 142(3-4):177-83. PubMed ID: 19913369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2.
    Kixmöller M; Ritzmann M; Eddicks M; Saalmüller A; Elbers K; Fachinger V
    Vaccine; 2008 Jun; 26(27-28):3443-51. PubMed ID: 18513842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccination of porcine circovirus type 2 (PCV2)-infected sows against porcine Parvovirus (PPV) and Erysipelas: effect on post-weaning multisystemic wasting syndrome (PMWS) and on PCV2 genome load in the offspring.
    Rose N; Blanchard P; Cariolet R; Grasland B; Amenna N; Oger A; Durand B; Balasch M; Jestin A; Madec F
    J Comp Pathol; 2007; 136(2-3):133-44. PubMed ID: 17374380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of porcine reproductive and respiratory syndrome virus and porcine circovirus-2 infection on the potency of the classical swine fever vaccine (LOM strain).
    Lim SI; Jeoung HY; Kim B; Song JY; Kim J; Kim HY; Cho IS; Woo GH; Lee JB; An DJ
    Vet Microbiol; 2016 Sep; 193():36-41. PubMed ID: 27599928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain.
    Martelli P; Cordioli P; Alborali LG; Gozio S; De Angelis E; Ferrari L; Lombardi G; Borghetti P
    Vaccine; 2007 Apr; 25(17):3400-8. PubMed ID: 17276558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental reproduction of severe wasting disease by co-infection of pigs with porcine circovirus and porcine parvovirus.
    Allan GM; Kennedy S; McNeilly F; Foster JC; Ellis JA; Krakowka SJ; Meehan BM; Adair BM
    J Comp Pathol; 1999 Jul; 121(1):1-11. PubMed ID: 10373289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model.
    Fort M; Sibila M; Pérez-Martín E; Nofrarías M; Mateu E; Segalés J
    Vaccine; 2009 Jun; 27(30):4031-7. PubMed ID: 19379787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody responses following vaccination versus infection in a porcine circovirus-type 2 (PCV2) disease model show distinct differences in virus neutralization and epitope recognition.
    Trible BR; Ramirez A; Suddith A; Fuller A; Kerrigan M; Hesse R; Nietfeld J; Guo B; Thacker E; Rowland RR
    Vaccine; 2012 Jun; 30(27):4079-85. PubMed ID: 22521847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the efficacy of a trivalent vaccine mixture against a triple challenge with Mycoplasma hyopneumoniae, PCV2, and PRRSV and the efficacy comparison of the respective monovalent vaccines against a single challenge.
    Oh T; Park KH; Yang S; Jeong J; Kang I; Park C; Chae C
    BMC Vet Res; 2019 Oct; 15(1):342. PubMed ID: 31619295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of porcine reproductive and respiratory syndrome virus and porcine circovirus type 2 in piglets after weaning on a commercial pig farm in Japan.
    Sasaki K; Tsukahara T; Taira O; Tsuchiya K; Itoh M; Ushida K
    Anim Sci J; 2010 Feb; 81(1):135-41. PubMed ID: 20163685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of antigenic epitopes of porcine reproductive and respiratory syndrome virus (PRRSV) in a modified live-attenuated porcine circovirus type 2 (PCV2) vaccine virus (PCV1-2a) as a potential bivalent vaccine against both PCV2 and PRRSV.
    Piñeyro PE; Kenney SP; Giménez-Lirola LG; Heffron CL; Matzinger SR; Opriessnig T; Meng XJ
    Virus Res; 2015 Dec; 210():154-64. PubMed ID: 26239318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concurrent vaccinations against PCV2 and PRRSV: study on the specific immunity and clinical protection in naturally infected pigs.
    Martelli P; Ardigò P; Ferrari L; Morganti M; De Angelis E; Bonilauri P; Luppi A; Guazzetti S; Caleffi A; Borghetti P
    Vet Microbiol; 2013 Mar; 162(2-4):558-571. PubMed ID: 23206413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Similarity of European porcine reproductive and respiratory syndrome virus strains to vaccine strain is not necessarily predictive of the degree of protective immunity conferred.
    Prieto C; Alvarez E; Martínez-Lobo FJ; Simarro I; Castro JM
    Vet J; 2008 Mar; 175(3):356-63. PubMed ID: 17560818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous detection of porcine circovirus type 2, classical swine fever virus, porcine parvovirus and porcine reproductive and respiratory syndrome virus in pigs by multiplex polymerase chain reaction.
    Jiang Y; Shang H; Xu H; Zhu L; Chen W; Zhao L; Fang L
    Vet J; 2010 Feb; 183(2):172-5. PubMed ID: 19131259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-time PCR for quantitation of porcine reproductive and respiratory syndrome virus and porcine circovirus type 2 in naturally-infected and challenged pigs.
    Chung WB; Chan WH; Chaung HC; Lien Y; Wu CC; Huang YL
    J Virol Methods; 2005 Mar; 124(1-2):11-9. PubMed ID: 15664045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection of pigs against post-weaning multisystemic wasting syndrome by a recombinant adenovirus expressing the capsid protein of porcine circovirus type 2.
    Wang X; Jiang P; Li Y; Jiang W; Dong X
    Vet Microbiol; 2007 Apr; 121(3-4):215-24. PubMed ID: 17215092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.